Volume 21, Issue 5, Pages (May 2014)

Slides:



Advertisements
Similar presentations
Supplementary Figures
Advertisements

Plk1 Controls the Nek2A-PP1γ Antagonism in Centrosome Disjunction
Volume 98, Issue 3, Pages (February 2010)
Volume 11, Issue 4, Pages (April 2003)
Volume 55, Issue 1, Pages (July 2014)
Volume 33, Issue 2, Pages (January 2009)
Volume 15, Issue 19, Pages (October 2005)
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
Phosphorylation of Cdc20 by Bub1 Provides a Catalytic Mechanism for APC/C Inhibition by the Spindle Checkpoint  Zhanyun Tang, Hongjun Shu, Dilhan Oncel,
Volume 28, Issue 3, Pages (September 2015)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 87, Issue 7, Pages (December 1996)
Volume 9, Issue 1, Pages (January 2009)
Volume 11, Issue 6, Pages (June 2010)
AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation  Graeme J. Gowans,
Volume 45, Issue 3, Pages (February 2012)
Deubiquitination and Activation of AMPK by USP10
Volume 21, Issue 11, Pages (November 2014)
Erica M. Dutil, Alex Toker, Alexandra C. Newton  Current Biology 
Volume 15, Issue 1, Pages (January 2012)
Volume 15, Issue 11, Pages (November 2008)
Volume 18, Issue 13, Pages (March 2017)
Volume 13, Issue 22, Pages (November 2003)
Volume 21, Issue 4, Pages (February 2006)
Volume 15, Issue 4, Pages (April 2008)
Plk1 Controls the Nek2A-PP1γ Antagonism in Centrosome Disjunction
Esther B.E. Becker, Azad Bonni  Neuron 
PKA phosphorylates Thr63 and Ser692 to increase HIF-1α stability.
Leslie A. Nangle, Candace M. Motta, Paul Schimmel  Chemistry & Biology 
Volume 22, Issue 15, Pages (August 2012)
Volume 23, Issue 5, Pages (May 2013)
Volume 22, Issue 6, Pages (June 2015)
Volume 19, Issue 7, Pages (July 2012)
Volume 21, Issue 11, Pages (November 2013)
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
Charlene Depry, Sohum Mehta, Ruojing Li, Jin Zhang  Chemistry & Biology 
A Structure-Guided Approach to Creating Covalent FGFR Inhibitors
Volume 17, Issue 2, Pages (January 2007)
Volume 17, Issue 5, Pages (March 2007)
Volume 18, Issue 2, Pages (January 2017)
Volume 23, Issue 2, Pages e6 (February 2018)
Volume 24, Issue 12, Pages e5 (September 2018)
Volume 22, Issue 8, Pages (August 2015)
Volume 19, Issue 7, Pages (July 2012)
Volume 23, Issue 2, Pages e6 (February 2018)
Volume 13, Issue 10, Pages (May 2003)
Rsk1 mediates a MEK–MAP kinase cell survival signal
Volume 18, Issue 2, Pages (February 2011)
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases  Sanjay B.
D. Grahame Hardie, Fiona A. Ross, Simon A. Hawley  Chemistry & Biology 
Volume 19, Issue 14, Pages (July 2009)
Volume 25, Issue 5, Pages (March 2007)
Regulation of protein kinase C ζ by PI 3-kinase and PDK-1
Volume 52, Issue 2, Pages (October 2013)
Volume 18, Issue 20, Pages (October 2008)
Volume 62, Issue 4, Pages (May 2016)
Structural Insight into BLM Recognition by TopBP1
Volume 21, Issue 12, Pages (June 2011)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Nitobe London, Steven Ceto, Jeffrey A. Ranish, Sue Biggins 
Jue Wang, Jia-Wei Wu, Zhi-Xin Wang  Structure 
Volume 68, Issue 3, Pages e5 (November 2017)
Michael J. Lee, Henrik G. Dohlman  Current Biology 
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Volume 55, Issue 1, Pages (July 2014)
Phosphorylation and Functional Inactivation of TSC2 by Erk
Volume 11, Issue 5, Pages (May 2010)
Volume 22, Issue 3, Pages (May 2006)
Volume 11, Issue 2, Pages (February 2018)
Presentation transcript:

Volume 21, Issue 5, Pages 619-627 (May 2014) Small Molecule Drug A-769662 and AMP Synergistically Activate Naive AMPK Independent of Upstream Kinase Signaling  John W. Scott, Naomi Ling, Samah M.A. Issa, Toby A. Dite, Matthew T. O’Brien, Zhi-Ping Chen, Sandra Galic, Christopher G. Langendorf, Gregory R. Steinberg, Bruce E. Kemp, Jonathan S. Oakhill  Chemistry & Biology  Volume 21, Issue 5, Pages 619-627 (May 2014) DOI: 10.1016/j.chembiol.2014.03.006 Copyright © 2014 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2014 21, 619-627DOI: (10. 1016/j. chembiol. 2014 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 Phosphorylation of β-Ser108 Is Sufficient for A-769662 Allosteric Activation of AMPK For direct activation, activities of AMPK (His6-α1β1γ1) expressed in E. coli were measured by SAMS assay following incubation with A-769662 (20 μM, open bars) or AMP (200 μM, gray bars). WT or mutant α- and β subunits are indicated, along with enzyme pretreatment and induction temperature. The data are presented as means ± SEM (n = 4). (A) A-769662 allosteric activation of AMPK is independent of α-Thr172 phosphorylation. A significant difference in fold activation with A-769662 between AMPKT172A and λ phosphatase-treated, WT AMPK is shown (∗∗∗∗p < 0.0001). Immunoblot shows α-pThr172 levels for each preparation. (B) Fold activation, calculated from data in (A). (C) Immunoblot showing relative changes in β-pSer108 and α-pThr172 as a result of induction temperature and enzyme pretreatment. (D) A-769662-stimulated activity of AMPK is commensurate with the extent of β-Ser108 phosphorylation. Activities of untreated AMPK preparations immunoblotted in (C) were measured with A-769662. (E) Sensitivity to A-769662 allosteric activation is restored following substitution of β-Ser108 for Glu. Significant differences in fold activation with A-769662 between β mutants S108A and S108D (∗p < 0.05) or S108E (∗∗∗∗p < 0.0001) are shown. (F) Fold activation, calculated from data in (E). (G) A-769662 dose-response curves for direct activation of AMPK (WT and indicated mutants). The data are presented as means ± SEM (n = 4). (H) Autophosphorylated residues other than β-Ser108 do not contribute to A-769662 allosteric activation of AMPK. Chemistry & Biology 2014 21, 619-627DOI: (10.1016/j.chembiol.2014.03.006) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 Regulation of β-Ser108 Phosphorylation (A) In vitro phosphorylation of bacterial-expressed AMPK by CaMKKβ. 400 ng of total AMPK (either AMPKS108A or λ phosphatase-treated WT (dephos.) individually or 1:1 mixtures of AMPKS108A + WT (dephos.) or AMPKS108A + AMPKKD) was incubated with 2 mM MgCl2, 200 μM ATP ± 50 ng of CaMKKβ for 30 min at 32°C. Assays were terminated by addition of SDS sample buffer and immunoblotted for β-pSer108, α-pThr172, and total α. A representative immunoblot from three independent experiments is shown. (B) α-Thr172 and β-Ser108 phosphorylation (normalized against α subunit and FLAG (β subunit), respectively) were measured by immunoblot in AMPK isolated from transfected COS7 cells, following initial incubation ± ionomycin and subsequent incubation ± STO-609. The data are presented as means ± SEM (n = 4). Statistical analysis was performed by two-way ANOVA. Significant differences between basal and treated levels of α-pThr172 and β-pSer108 (∗∗∗p < 0.001; ∗∗∗∗p < 0.0001) and between fold increases in α-pThr712 and β-pSer108 at each time point (††p < 0.01; ††††p < 0.0001) are indicated. A representative immunoblot is shown. Inset: bacterial-expressed AMPK, maximally phosphorylated by CaMKKβ, was mixed with dephosphorylated AMPK to generate standards of known α-pThr172 and β-pSer108 stoichiometry (% phos). (C) COS7 cells transfected to express WT AMPK or AMPKKD were incubated with ionomycin. Isolated recombinant AMPK and endogenous AMPK from lysates were immunoblotted for β-pSer108 and/or α-pThr172. A representative immunoblot from three independent experiments is shown. (D) In vitro α-pThr172 and β-pSer108 dephosphorylation by PP2Cα and λ phosphatase. The data are presented as means ± SEM (n = 6). Significant difference between percentage of residual α-pThr172 and β-pSer108 following PP2Cα treatment is indicated (∗∗∗∗p < 0.0001). A representative immunoblot is shown. Chemistry & Biology 2014 21, 619-627DOI: (10.1016/j.chembiol.2014.03.006) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 3 AMP and A-769662 Synergistically Activate AMPK Independently of α-Thr172 and β-Ser108 Phosphorylation For direct activation, activities of AMPK (GST-α1β1γ1) expressed in COS7 cells were measured by SAMS assay unless stated, using 100 μM AMP/ADP and 20 μM A-769662 as indicated. WT or mutant α- and β subunits are indicated. The data are presented as means ± SEM (n = 4). (A) AMPK activities with A-769662 (open bars), AMP (light gray bars), or AMP and A-769662 (dark gray bars). Significant differences in fold activation of AMPKT172A/S108A between individual incubations and coincubation are shown (∗∗∗∗p < 0.0001). (B) Fold activation, calculated from data in (A). (C) AMP/A-769662 synergistic activation of AMPK is CBM dependent. Activities of AMPKT172A/S108A and truncated complex AMPKT172A/ΔCBM were measured with A-769662 (open bars) or AMP and A-769662 (dark gray bars). A significant difference in fold activation with AMP/A-769662 coincubation of AMPKT172A/S108A is shown (∗∗∗p < 0.001). (D) AMP/A-769662 coincubation stimulates phosphorylation of ACC1-Ser79. ACC1 was phosphorylated by AMPKT172A/S108A with A-769662 (open bars), AMP (light gray bars), or AMP and A-769662 (dark gray bars). Increases in pSer79 compared to basal (untreated control) are presented. A representative immunoblot is shown. (E) ADP and A-769662 do not synergistically activate AMPK. A significant difference in fold activation between AMP/A-769662 and ADP/A-769662 coincubations is shown (∗∗∗∗p < 0.0001). Chemistry & Biology 2014 21, 619-627DOI: (10.1016/j.chembiol.2014.03.006) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 4 A-769662/AMP Dose Response for AMPK Activation A-769662 (A) and AMP (B) dose-response curves at fixed AMP (100 μM) or A-769662 (20 μM), respectively, for direct activation of λ phosphatase-treated, COS7 cell-expressed AMPK. The data are presented as means ± SEM (n = 4). Chemistry & Biology 2014 21, 619-627DOI: (10.1016/j.chembiol.2014.03.006) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 5 γ-Nucleotide-Binding Sites 1, 3, and 4 Are Required for AMP/A-769662 Synergistic Activation of AMPK For direct activation, activities of AMPKT172A/S108A expressed in COS7 cells with γ mutants as indicated were measured by SAMS assay using A-769662 (20 μM) (open bars) or AMP (100 μM) and A-769662 (20 μM) together (dark gray bars). The data are presented as means ± SEM (n = 4). Significant differences in AMP/A-769662 fold activation between WT γ and γ-Asp mutants are shown (∗∗∗∗p < 0.0001). Chemistry & Biology 2014 21, 619-627DOI: (10.1016/j.chembiol.2014.03.006) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 6 Hypothetical Model of Allosteric Regulation of AMPK by AMP and A-769662 AMP and A-769662 synergistic (solid arrow) and individual (dashed arrows) direct activation of AMPK in various α-Thr172 and β-Ser108 phosphorylation states, in the context of the AMPK activation cycle in response to cellular energy charge depletion. AMP-stimulated α-Thr172 phosphorylation (red button) by upstream kinases results in basal AMPK activity (orange) and β-Ser108 autophosphorylation (blue button). Rapid α-pThr172 dephosphorylation results in β-Ser108-phosphorylated AMPK that is sensitive to drug alone. In vitro fold activation by AMP and/or A-769662 of AMPK in each phosphorylation state is indicated. ∗90-fold activation by A-769662 is most likely an underestimation because bacterial-expressed AMPK used to generate the data consistently displayed higher basal activity than α-Thr172 dephosphorylated AMPK expressed in COS7 cells. Chemistry & Biology 2014 21, 619-627DOI: (10.1016/j.chembiol.2014.03.006) Copyright © 2014 Elsevier Ltd Terms and Conditions